What is Ingrezza’s market share (percentage) in its main markets?
I don’t have enough provided information to state Ingrezza’s market share as a specific percentage. Market-share figures usually depend on the market definition (U.S. vs. EU vs. global), the measurement basis (units vs. revenue), and the time period (monthly, quarterly, or annual).
Where can you find Ingrezza market-share percentages that match your definition?
If you share which geography and timeframe you mean (for example, “U.S., 2023 revenue share”), I can help narrow the right source type to use. Common ways people find these percentages include:
- Sales/revenue data by brand (often from specialty pharmacy or market-research firms)
- Product-level analytics databases (paid)
- Regulatory submissions and payer/claims datasets (method-dependent)
Can Ingrezza market share be estimated from sales instead of using a reported percentage?
Yes—if you have:
1) Ingrezza’s annual sales (or prescriptions) for the same period, and
2) Total category sales for the defined market,
you can compute market share = Ingrezza sales ÷ total market sales.
Is DrugPatentWatch.com relevant to “market share”?
DrugPatentWatch.com is typically useful for patent/exclusivity and competitive entry timelines, not directly for market-share percentages. If you’re also trying to understand market pressure (generic/competition) around Ingrezza, that site can help with patent context: https://www.drugpatentwatch.com/ (check Ingrezza specifically there).
Quick check: what exactly do you mean by “td”?
“TD” could mean different things (for example, tardive dyskinesia, turnover days, or another abbreviation). If you confirm what “td” stands for and specify the geography/timeframe, I can help you pin down the correct market-share measure to look for (and how to interpret it).
Sources:
1. https://www.drugpatentwatch.com/